Potential roles of gut microbiome and metabolites in modulating ALS in mice

Eran Blacher(Weizmann Institute of Science), Stavros Bashiardes(Weizmann Institute of Science), Hagit Shapiro(Weizmann Institute of Science), Daphna Rothschild(Weizmann Institute of Science), Uria Mor(Weizmann Institute of Science), Mally Dori-Bachash(Weizmann Institute of Science), Christian Kleimeyer(Weizmann Institute of Science), Claudia Moresi(Weizmann Institute of Science), Yotam Harnik(Weizmann Institute of Science), Maya Zur(Weizmann Institute of Science), Michal Zabari(Hadassah Medical Center), Rotem Ben-Zeev Brik(Weizmann Institute of Science), Denise Kviatcovsky(Weizmann Institute of Science), Niv Zmora(Weizmann Institute of Science), Yotam Cohen(Weizmann Institute of Science), Noam Bar(Weizmann Institute of Science), Izhak Levi(Weizmann Institute of Science), Nira Amar(Weizmann Institute of Science), Tevie Mehlman(Weizmann Institute of Science), Alexander Brandis(Weizmann Institute of Science), Inbal Biton(Weizmann Institute of Science), Yael Kuperman(Weizmann Institute of Science), Michael Tsoory(Weizmann Institute of Science), Leenor Alfahel(Ben-Gurion University of the Negev), Alon Harmelin(Weizmann Institute of Science), Michal Schwartz(Weizmann Institute of Science), Adrian Israelson(Ben-Gurion University of the Negev), Liisa Arike(University of Gothenburg), Malin Johansson(University of Gothenburg), Gunnar C. Hansson(University of Gothenburg), Marc Gotkine(Hadassah Medical Center), Eran Segal(Weizmann Institute of Science), Eran Elinav(German Cancer Research Center)
Nature
July 22, 2019
Cited by 712

Abstract


Related Papers

No related papers found

Powered by citation graph analysis